<DOC>
	<DOCNO>NCT02183935</DOCNO>
	<brief_summary>Obesity complication significant effect morbidity mortality subject . Especially risk subject extremely increase BMI ( 99th percentile age gender adolescent ) . In subject classical treatment diet cognitive therapy limited effect . Bariatric procedure , moment , feasible therapeutic possibility . Bariatric procedure base several principle ; restrictive , malabsorptive combine . They surgical endoscopic . The later use subject qualify surgical procedure decline use planed definite bariatric procedure . Duodena-jejunal liner ( DJL ) endoscopic tool , efficiently safely used decrease body weight ameliorated obesity complication , especially associate diabetic state . Aims study : - To determine ( short long-term ) efficacy DJL decrease body weight adolescent . - To determine ( short long-term ) efficacy DJL ameliorate complication morbid obesity - abnormal glucose metabolism , dislipidemia , alter adipokine secretion pattern , alter secretion pattern gastrointestinal hormone adolescent . - To visualize functional alternation select central nervous system region associate appetite regulation upon insertion DJL .</brief_summary>
	<brief_title>Treatment Morbidly Obese Adolescent With Duodena-jejunal Liner</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Subjects estimate fully comply study protocol sign informed consent form . Age &gt; 15 year . BMI â‰¥ 99. percentile age gender . Inefficient conservative measure ( least 6 month duration ) decrease body weight ( characterized decrease BMI &gt; 10 % ) . Documented negative pregnancy test woman childbearing potential . Women childbearing potential agree remain contraceptive duration trial participation . Previous GI surgery could potentially affect ability place sleeve affect function implant . Subjects congenital acquire anomaly GI tract opinion investigator , may impair implantation EndoBarrier device . Subjects gastrooesophageal reflucs disease.. Known abnormal pathology condition gastrointestinal tract , include ulcer Crohn 's disease , upper gastrointestinal bleeding condition . Coagulopathy define Hgb &lt; 10g/dl platelet &lt; 100,000/ml diagnosis severe coagulopathy like hemophilia . Any documented history acute chronic pancreatitis . Subjects require regular antithrombotic therapy ( i.e . anticoagulant antiplatelet agent ) . Known diagnosis systemic lupus erythematosus , scleroderma autoimmune connective tissue disorder . Subject enrol another investigational study within 6 month participation EndoBarrier study . Subjects mentally retard emotionally unstable . Subjects pregnant breastfeeding . Subjects abnormal laboratory ECG abnormality investigator deem clinically significant make patient poor candidate study .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Gut hormone</keyword>
	<keyword>Adipokines</keyword>
	<keyword>Appetite</keyword>
	<keyword>Adolescent</keyword>
</DOC>